BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12176782)

  • 1. Sequential immunochemotherapy and edrecolomab in the adjuvant therapy of breast cancer: reduction of 17-1A-positive disseminated tumour cells.
    Kirchner EM; Gerhards R; Voigtmann R
    Ann Oncol; 2002 Jul; 13(7):1044-8. PubMed ID: 12176782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
    Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
    Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of high-dose chemotherapy and monoclonal antibody in breast-cancer patients: a pilot trial to monitor treatment effects on disseminated tumor cells.
    Hempel P; Müller P; Oruzio D; Behr W; Brockmeyer C; Wochner M; Ehnle S; Riethmüller R; Schlimok G
    Cytotherapy; 2000; 2(4):287-95. PubMed ID: 12042038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease.
    Braun S; Hepp F; Sommer HL; Pantel K
    Int J Cancer; 1999 Feb; 84(1):1-5. PubMed ID: 9988223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edrecolomab (monoclonal antibody 17-1A).
    Adkins JC; Spencer CM
    Drugs; 1998 Oct; 56(4):619-26; discussion 627-8. PubMed ID: 9806108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study.
    Punt CJ; Nagy A; Douillard JY; Figer A; Skovsgaard T; Monson J; Barone C; Fountzilas G; Riess H; Moylan E; Jones D; Dethling J; Colman J; Coward L; MacGregor S
    Lancet; 2002 Aug; 360(9334):671-7. PubMed ID: 12241873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
    Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
    Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
    Kasimir-Bauer S; Oberhoff C; Schindler AE; Seeber S
    Int J Oncol; 2002 May; 20(5):1027-34. PubMed ID: 11956600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma.
    Schwartzberg LS
    Crit Rev Oncol Hematol; 2001 Oct; 40(1):17-24. PubMed ID: 11578913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
    Braun S; Pantel K; Müller P; Janni W; Hepp F; Kentenich CR; Gastroph S; Wischnik A; Dimpfl T; Kindermann G; Riethmüller G; Schlimok G
    N Engl J Med; 2000 Feb; 342(8):525-33. PubMed ID: 10684910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.
    Braun S; Kentenich C; Janni W; Hepp F; de Waal J; Willgeroth F; Sommer H; Pantel K
    J Clin Oncol; 2000 Jan; 18(1):80-6. PubMed ID: 10623696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study.
    Hartung G; Hofheinz RD; Dencausse Y; Sturm J; Kopp-Schneider A; Dietrich G; Fackler-Schwalbe I; Bornbusch D; Gonnermann M; Wojatschek C; Lindemann W; Eschenburg H; Jost K; Edler L; Hochhaus A; Queisser W
    Onkologie; 2005 Jun; 28(6-7):347-50. PubMed ID: 15933423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node micrometastasis and distant failure in breast cancer patients.
    Nagashima T; Sakakibara M; Nakano S; Tanabe N; Nakamura R; Nakatani Y; Nagai Y; Koda K; Miyazaki M
    Breast Cancer; 2006; 13(2):186-91. PubMed ID: 16755115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.
    Harbeck N; Untch M; Pache L; Eiermann W
    Br J Cancer; 1994 Mar; 69(3):566-71. PubMed ID: 7510120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and management of bone marrow micrometastases in breast cancer.
    Osborne MP; Rosen PP
    Oncology (Williston Park); 1994 Aug; 8(8):25-31; discussion 35-6, 39-42. PubMed ID: 7947000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow micrometastases and adjuvant treatment of breast cancer.
    Yu JJ; Brennan M; Christos P; Osborne MP; Hoda S; Simmons RM
    Breast J; 2004; 10(3):181-5. PubMed ID: 15125741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome.
    Synnestvedt M; Borgen E; Schlichting E; Schirmer CB; Renolen A; Giercksky KE; Nesland JM; Naume B
    Breast Cancer Res Treat; 2013 Apr; 138(2):485-97. PubMed ID: 23456230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis.
    Thorban S; Rosenberg R; Busch R; Roder RJ
    Br J Cancer; 2000 Jul; 83(1):35-9. PubMed ID: 10883665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
    Tsavaris NB; Katsoulas HL; Kosmas C; Papalambros E; Gouveris P; Papantoniou N; Rokana S; Kosmas N; Skopeliti M; Tsitsilonis OE
    Oncology; 2004; 67(5-6):403-10. PubMed ID: 15713997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.
    Schlimok G; Funke I; Holzmann B; Göttlinger G; Schmidt G; Häuser H; Swierkot S; Warnecke HH; Schneider B; Koprowski H; Riethmüller G
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8672-6. PubMed ID: 2446326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.